Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bausch & Lomb eye laser steps closer to market:

This article was originally published in Clinica

Executive Summary

Bausch & Lomb (B&L) is close to releasing its customisable laser vision correction system, Zyoptix, in the US following receipt of an approvable letter from the FDA. The letter signifies that the firm has largely fulfilled the agency's requirements for premarket approval, but asks for certain labelling changes. B&L says it expects final approval in the third quarter of 2003. Shares in rival US firm Visx dipped slightly following the B&L news. Visx sells an FDA-approved customisable laser system called CustomVue.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT063479

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel